Prescription drug · ANDA
Doxycycline Hyclate NDC 71335-2113
Doxycycline hyclate 100 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-2113-1 | 71335211301 | 20 TABLET in 1 BOTTLE (71335-2113-1)Marketed from Jan 31, 2025 | |
| 71335-2113-2 | 71335211302 | 30 TABLET in 1 BOTTLE (71335-2113-2)Marketed from Sep 7, 2022 | |
| 71335-2113-3 | 71335211303 | 50 TABLET in 1 BOTTLE (71335-2113-3)Marketed from Sep 7, 2022 | |
| 71335-2113-4 | 71335211304 | 14 TABLET in 1 BOTTLE (71335-2113-4)Marketed from Jan 31, 2025 | |
| 71335-2113-5 | 71335211305 | 40 TABLET in 1 BOTTLE (71335-2113-5)Marketed from Jan 31, 2025 | |
| 71335-2113-6 | 71335211306 | 60 TABLET in 1 BOTTLE (71335-2113-6)Marketed from Jan 31, 2025 | |
| 71335-2113-7 | 71335211307 | 28 TABLET in 1 BOTTLE (71335-2113-7)Marketed from Jan 31, 2025 | |
| 71335-2113-8 | 71335211308 | 10 TABLET in 1 BOTTLE (71335-2113-8)Marketed from Jan 31, 2025 | |
| 71335-2113-9 | 71335211309 | 6 TABLET in 1 BOTTLE (71335-2113-9)Marketed from Jan 31, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxycycline Hyclate
- Generic name (nonproprietary)
- doxycycline hyclate
- Active ingredients
- Doxycycline hyclate — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207773
- Marketing start
- Listing expires
- Other FDA classes
- Tetracyclines (Chemical structure)
- Identifiers
- Product ID 71335-2113_2a8fc1ec-e0ab-4418-ac20-93d68fa4a5fcSPL ID 2a8fc1ec-e0ab-4418-ac20-93d68fa4a5fcSPL set ID 5b4390ed-a0ec-4ef8-864c-8a33a83653f9RxCUI 1650143UNII 19XTS3T51U
- Pharmacologic class
- Tetracycline-class Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335211301followed by a unit qualifier and the quantityPackage 71335-2113-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 207773
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxycycline hyclate | Doxycycline hyclate 100 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1104 |
| Doxycycline Hyclate | Doxycycline hyclate 100 mg/1 | TabletOral | RedPharm Drug, Inc. | 67296-1431 |
| Doxycycline Hyclate | Doxycycline hyclate 100 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8529 |
| Doxycycline Hyclate | Doxycycline hyclate 100 mg/1 | TabletOral | Viona Pharmaceuticals Inc | 72578-001 |